Streetbeat News

Analyst Ratings

LTHM

Keybanc analyst Aleksey Yefremov maintains an Overweight rating on Livent (NYSE:LTHM) and raises the price target from $32 to $35.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 8:08 am

FMC

Keybanc analyst Aleksey Yefremov has maintained an Overweight rating on FMC (NYSE:FMC) but lowered the price target from $144 to $128.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 8:07 am

EMN

Keybanc analyst Aleksey Yefremov maintains an Overweight rating on Eastman Chemical (NYSE:EMN) but lowers the price target from $106 to $103.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 8:06 am

CTVA

Keybanc analyst Aleksey Yefremov has maintained an Overweight rating on Corteva (NYSE:CTVA) but lowered the price target from $70 to $68.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 8:05 am

AXTA

Keybanc analyst Aleksey Yefremov maintains an Overweight rating on Axalta Coating Sys (NYSE:AXTA) and raises the price target from $36 to $38.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 8:04 am

AMD

Keybanc analyst John Vinh maintains an Overweight rating on Advanced Micro Devices (AMD) and raises the price target from $150 to $160.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 8:03 am

AAPL

Keybanc analyst Brandon Nispel maintains an Overweight rating on Apple (NASDAQ:AAPL) and raises the price target from $180 to $200.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 8:02 am

AAPL

KeyBanc Capital Markets analyst, Brandon Nispel, has maintained an Overweight rating for Apple Inc. (AAPL) and increased the price target from $180 to $200, despite predicting a 19% quarter-over-quarter decline in U.S. hardware revenue for the June quarter. The analyst cites lukewarm consumer spending data and softness in Apple's indirect channel as reasons for the muted expectation. However, the bull case for the stock is due to excitement around new products and investors reaching for safety.

Portfolio Pulse from Shanthi Rexaline

July 11, 2023 | 8:00 am

LBPH

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Longboard Pharmaceuticals (NASDAQ:LBPH) and maintained a $25 price target.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 8:00 am

SSTK

Needham analyst Bernie McTernan has reiterated a 'Buy' rating on Shutterstock (NYSE:SSTK) and maintained a price target of $90.

Portfolio Pulse from richadhand@benzinga.com

July 11, 2023 | 7:58 am